8-K Announcements
6Material company update
May 28, 2026·SEC
Material company update
May 8, 2026·SEC
Material company update
Apr 6, 2026·SEC
HealthEquity, Inc.(HQY)Earnings, Financials & Key Ratios
HQY•NASDAQ
34.6× P/E·Price updated Jun 19, 2026
AboutHealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.Show more
- Revenue$1.31B+9.5%
- EBITDA$322M-17.8%
- Net Income$215M+122.5%
- EPS (Diluted)2.46+125.7%
- Gross Margin69.52%+20.4%
- EBITDA Margin24.55%-25.0%
- Operating Margin24.55%+28.0%
- Net Margin16.38%+103.3%
- ROE10.19%+118.7%
HQY Key Insights
HealthEquity, Inc. (HQY) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y profit CAGR of 89.4%
- ✓Strong Piotroski F-Score: 9/9
- ✓FCF machine: 34.7% free cash flow margin
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 12.4%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when HQY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
HQY Price & Volume
HealthEquity, Inc. (HQY) stock price & volume — 10-year historical chart
Loading chart...
HQY Growth Metrics
HealthEquity, Inc. (HQY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years26.34%
5 Years12.36%
3 Years15.08%
TTM7.58%
Profit CAGR
10 Years29.19%
5 Years89.38%
3 Years-
TTM89.4%
EPS CAGR
10 Years24.27%
5 Years82.96%
3 Years-
TTM94.28%
Return on Capital
10 Years8.89%
5 Years4.82%
3 Years7.12%
Last Year9.82%
HQY Recent Earnings
HealthEquity, Inc. (HQY) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
May 28, 2026Metric
Actual
Est
EPS
$1.24+11.7%
$1.11
Rev
$355M+0.7%
$352M
Q2 2026
Mar 17, 2026Metric
Actual
Est
EPS
$0.95+6.7%
$0.89
Rev
$335M+0.7%
$332M
Q4 2025
Dec 3, 2025Metric
Actual
Est
EPS
$1.01+10.7%
$0.91
Rev
$322M+0.5%
$321M
Q4 2025
Sep 2, 2025Metric
Actual
Est
EPS
$1.08+18.2%
$0.91
Rev
$326M+1.6%
$321M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 28, 2026 | $1.24vs $1.11+11.7% | $355Mvs $352M+0.7% |
| Q2 2026 | Mar 17, 2026 | $0.95vs $0.89+6.7% | $335Mvs $332M+0.7% |
| Q4 2025 | Dec 3, 2025 | $1.01vs $0.91+10.7% | $322Mvs $321M+0.5% |
| Q4 2025 | Sep 2, 2025 | $1.08vs $0.91+18.2% | $326Mvs $321M+1.6% |
Based on last 12 quarters of dataView full earnings history →
HQY Peer Comparison
HealthEquity, Inc. (HQY) competitors in Payer and Benefits Administration — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 WEX | 4.42B | 127.53 | 15.06 | 1.24% | 11.5% | 26.96% | 3.94 | |
 BEN | 17.17B | 33.05 | 36.32 | 3.45% | 8.99% | 5.64% | 0.94 | |
 INVA | 1.66B | 22.49 | 6.82 | 18.52% | 118.91% | 47.59% | 0.23 | |
 GWRE | 8.98B | 107.86 | 133.16 | 22.64% | 11.25% | 10.99% | 0.49 | |
 PCTY | 5.41B | 101.06 | 25.14 | 13.74% | 14.94% | 22.36% | 0.18 | |
 PAYC | 6.81B | 124.85 | 15.45 | 8.95% | 22.44% | 31.03% | 0.09 | |
 ADP | 87.94B | 218.41 | 21.88 | 7.07% | 20.12% | 68.69% | 1.46 | |
 PAYX | 35.27B | 98.24 | 21.45 | 5.56% | 26.45% | 41.13% | 1.22 |
Compare HQY vs Peers
HealthEquity, Inc. (HQY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
HQY Income Statement
HealthEquity, Inc. (HQY) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 229.53M | 287.24M | 531.99M | 733.57M | 756.56M | 861.75M | 999.59M | 1.2B | 1.31B | 1.34B |
Revenue Growth % | 28.68% | 25.15% | 85.21% | 37.89% | 3.13% | 13.9% | 16% | 20.03% | 9.47% | 7.58% |
Cost of Goods Sold | 99.47M | 111.98M | 240.79M | 394.3M | 415.64M | 466.24M | 469.71M | 507.19M | 400.31M | 365.11M |
COGS % of Revenue | 43.34% | 38.98% | 45.26% | 53.75% | 54.94% | 54.1% | 46.99% | 42.27% | 30.48% | - |
Gross Profit | 130.05M▲ 0% | 175.26M▲ 34.8% | 291.2M▲ 66.2% | 339.27M▲ 16.5% | 340.92M▲ 0.5% | 395.5M▲ 16.0% | 529.87M▲ 34.0% | 692.58M▲ 30.7% | 913.12M▲ 31.8% | 972.12M▲ 0% |
Gross Margin % | 56.66% | 61.02% | 54.74% | 46.25% | 45.06% | 45.9% | 53.01% | 57.73% | 69.52% | 72.7% |
Gross Profit Growth % | 27.43% | 34.76% | 66.15% | 16.51% | 0.48% | 16.01% | 33.97% | 30.71% | 31.84% | - |
Operating Expenses | 75.64M | 97.59M | 182.09M | 259.27M | 300.35M | 357.85M | 401.74M | 462.51M | 590.66M | 631.06M |
OpEx % of Revenue | 32.95% | 33.98% | 34.23% | 35.34% | 39.7% | 41.53% | 40.19% | 38.55% | 44.97% | - |
Selling, General & Admin | 48.25M | 62.54M | 104.51M | 134.46M | 142.98M | 164.48M | 182.93M | 223M | 328.15M | 334.59M |
SG&A % of Revenue | 21.02% | 21.77% | 19.65% | 18.33% | 18.9% | 19.09% | 18.3% | 18.59% | 24.98% | - |
Research & Development | 27.39M | 35.06M | 77.58M | 124.81M | 157.36M | 193.38M | 218.81M | 239.51M | 262.51M | 268.84M |
R&D % of Revenue | 11.93% | 12.2% | 14.58% | 17.01% | 20.8% | 22.44% | 21.89% | 19.96% | 19.99% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K |
Operating Income | 54.42M▲ 0% | 77.67M▲ 42.7% | 109.12M▲ 40.5% | 80M▼ 26.7% | 40.57M▼ 49.3% | 37.65M▼ 7.2% | 128.13M▲ 240.3% | 230.07M▲ 79.6% | 322.46M▲ 40.2% | 341.06M▲ 0% |
Operating Margin % | 23.71% | 27.04% | 20.51% | 10.91% | 5.36% | 4.37% | 12.82% | 19.18% | 24.55% | 25.5% |
Operating Income Growth % | 32.04% | 42.73% | 40.49% | -26.68% | -49.29% | -7.18% | 240.3% | 79.55% | 40.16% | - |
EBITDA | 70.37M | 95.86M | 164.47M | 195.91M | 177.75M | 198.85M | 281.21M | 392.52M | 322.46M | 314.94M |
EBITDA Margin % | 30.66% | 33.37% | 30.92% | 26.71% | 23.5% | 23.08% | 28.13% | 32.72% | 24.55% | 23.55% |
EBITDA Growth % | 29.36% | 36.22% | 71.58% | 19.12% | -9.27% | 11.87% | 41.42% | 39.58% | -17.85% | -27.25% |
D&A (Non-Cash Add-back) | 15.95M | 18.18M | 55.35M | 115.9M | 137.19M | 161.2M | 153.08M | 162.45M | 0 | -26.11M |
EBIT | 52.46M | 76.09M | 67.93M | 39.02M | -34.22M | 10.33M | 129.34M | 175.09M | 322.46M | 329.97M |
Net Interest Income | -274K | 1.68M | -18.87M | -33.84M | -35.07M | -46.66M | -43.32M | -46.72M | -45.02M | -43.6M |
Interest Income | 0 | 1.68M | 5.91M | 1.04M | 1.5M | 1.76M | 12.14M | 13.91M | 12.11M | 11.26M |
Interest Expense | 274K | 0 | 24.77M | 34.88M | 36.57M | 48.42M | 55.45M | 60.63M | 57.13M | 54.86M |
Other Income/Expense | -2.23M | -1.85M | -65.96M | -75.86M | -107.31M | -75.75M | -53.09M | -114.03M | -45.02M | -42.16M |
Pretax Income | 52.19M▲ 0% | 75.82M▲ 45.3% | 43.16M▼ 43.1% | 4.14M▼ 90.4% | -66.74M▼ 1712.1% | -38.1M▲ 42.9% | 75.04M▲ 297.0% | 116.03M▲ 54.6% | 277.43M▲ 139.1% | 298.89M▲ 0% |
Pretax Margin % | 22.74% | 26.4% | 8.11% | 0.56% | -8.82% | -4.42% | 7.51% | 9.67% | 21.12% | 22.35% |
Income Tax | 4.83M | 1.92M | 3.49M | -4.69M | -22.45M | -11.95M | 19.33M | 19.33M | 62.23M | 68.19M |
Effective Tax Rate % | 9.25% | 2.53% | 8.09% | -113.38% | 33.64% | 31.38% | 25.76% | 16.66% | 22.43% | 22.81% |
Net Income | 47.36M▲ 0% | 73.9M▲ 56.0% | 39.66M▼ 46.3% | 8.83M▼ 77.7% | -44.29M▼ 601.3% | -26.14M▲ 41.0% | 55.71M▲ 313.1% | 96.7M▲ 73.6% | 215.2M▲ 122.5% | 230.7M▲ 0% |
Net Margin % | 20.63% | 25.73% | 7.46% | 1.2% | -5.85% | -3.03% | 5.57% | 8.06% | 16.38% | 17.25% |
Net Income Growth % | 79.56% | 56.03% | -46.33% | -77.73% | -601.35% | 40.97% | 313.1% | 73.58% | 122.54% | 89.4% |
Net Income (Continuing) | 47.36M | 73.9M | 39.66M | 8.83M | -44.29M | -26.14M | 55.71M | 96.7M | 215.2M | 230.7M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | 0.77▲ 0% | 1.17▲ 51.9% | 0.58▼ 50.4% | 0.12▼ 79.3% | -0.53▼ 541.7% | -0.31▲ 41.5% | 0.64▲ 306.5% | 1.09▲ 70.3% | 2.46▲ 125.7% | 2.71▲ 0% |
EPS Growth % | 75% | 51.95% | -50.43% | -79.31% | -541.67% | 41.51% | 306.45% | 70.31% | 125.69% | 94.28% |
EPS (Basic) | 0.79 | 1.20 | 0.59 | 0.12 | -0.53 | -0.31 | 0.65 | 1.11 | 2.50 | - |
Diluted Shares Outstanding | 61.85M | 63.37M | 68.45M | 75.68M | 83.13M | 84.44M | 86.96M | 88.83M | 87.47M | 85.01M |
Basic Shares Outstanding | 60.3M | 61.84M | 67.03M | 74.23M | 83.13M | 84.44M | 85.56M | 86.87M | 86.13M | 84.41M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
HQY Balance Sheet
HealthEquity, Inc. (HQY) balance sheet — assets, liabilities & shareholders' equity
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 265.4M | 394.68M | 297.3M | 460.18M | 351.34M | 382.89M | 557.44M | 477.75M | 512.28M | 466.53M |
Cash & Short-Term Investments | 240.27M | 361.48M | 191.73M | 328.8M | 225.41M | 254.27M | 403.98M | 295.95M | 318.93M | 265.37M |
Cash Only | 199.47M | 361.48M | 191.73M | 328.8M | 225.41M | 254.27M | 403.98M | 295.95M | 318.93M | 265.37M |
Short-Term Investments | 40.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 21.6M | 25.67M | 70.86M | 72.77M | 87.43M | 96.83M | 104.89M | 118.01M | 123.7M | 122M |
Days Sales Outstanding | 34.35 | 32.62 | 48.62 | 36.21 | 42.18 | 41.02 | 38.3 | 35.9 | 34.37 | 31.94 |
Inventory | 215K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | 0.79 | - | - | - | - | - | - | - | - | - |
Other Current Assets | 3.31M | 7.53M | 34.71M | 58.61M | 38.49M | 31.79M | 48.56M | 63.8M | 69.66M | 79.16M |
Total Non-Current Assets | 103.76M | 115.34M | 2.27B | 2.25B | 2.76B | 2.71B | 2.61B | 2.97B | 2.92B | 2.84B |
Property, Plant & Equipment | 7.84M | 8.22M | 116.66M | 118.61M | 86.98M | 69.32M | 54.39M | 46.42M | 39.49M | 38.38M |
Fixed Asset Turnover | 29.29x | 34.93x | 4.56x | 6.18x | 8.70x | 12.43x | 18.38x | 25.84x | 33.26x | 32.99x |
Goodwill | 4.65M | 4.65M | 1.33B | 1.33B | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B | 1.65B |
Intangible Assets | 83.64M | 79.67M | 783.28M | 767M | 973.14M | 936.36M | 835.95M | 1.2B | 1.1B | 1.07B |
Long-Term Investments | 706K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.29M | 12.16M |
Other Non-Current Assets | 1.47M | 21.12M | 35.09M | 37.42M | 49.81M | 52.18M | 67.87M | 71.57M | 131.67M | 80.09M |
Total Assets | 369.16M▲ 0% | 510.02M▲ 38.2% | 2.56B▲ 402.9% | 2.71B▲ 5.7% | 3.11B▲ 14.6% | 3.09B▼ 0.6% | 3.16B▲ 2.4% | 3.45B▲ 9.0% | 3.43B▼ 0.5% | 3.31B▲ 0% |
Asset Turnover | 0.62x | 0.56x | 0.21x | 0.27x | 0.24x | 0.28x | 0.32x | 0.35x | 0.38x | 0.39x |
Asset Growth % | 32.25% | 38.16% | 402.92% | 5.67% | 14.64% | -0.59% | 2.42% | 9% | -0.48% | -9.07% |
Total Current Liabilities | 20.49M | 29.05M | 151.94M | 204.7M | 153.19M | 131.06M | 117.09M | 156.32M | 156.85M | 135.74M |
Accounts Payable | 2.42M | 3.52M | 3.98M | 1.61M | 27.54M | 13.9M | 12.04M | 14.36M | 12.16M | 14.22M |
Days Payables Outstanding | 8.88 | 11.47 | 6.03 | 1.49 | 24.19 | 10.88 | 9.36 | 10.33 | 11.09 | 13.88 |
Short-Term Debt | 0 | 0 | 39.06M | 62.5M | 8.75M | 17.5M | 0 | 0 | 9.91M | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 12.55M | 16.98M | 50.12M | 50.67M | 47.14M | 45.84M | 49.61M | 69.33M | 134.78M | 26.66M |
Current Ratio | 12.95x | 13.58x | 1.96x | 2.25x | 2.29x | 2.92x | 4.76x | 3.06x | 3.27x | 3.44x |
Quick Ratio | 12.94x | 13.58x | 1.96x | 2.25x | 2.29x | 2.92x | 4.76x | 3.06x | 3.27x | 3.44x |
Cash Conversion Cycle | 26.26 | - | - | - | - | - | - | - | - | 18.07 |
Total Non-Current Liabilities | 2.4M | 3.88M | 1.38B | 1.13B | 1.1B | 1.06B | 1.01B | 1.18B | 1.17B | 1.12B |
Long-Term Debt | 0 | 0 | 1.18B | 924.22M | 922.08M | 907.84M | 874.97M | 1.06B | 957.38M | 942.66M |
Capital Lease Obligations | 0 | 0 | 68.02M | 74.22M | 65.23M | 58.99M | 48.77M | 42.22M | 34.19M | 140.77M |
Deferred Tax Liabilities | 0 | 916K | 130.49M | 119.73M | 99.85M | 82.67M | 68.67M | 55.83M | 145.42M | 428.96M |
Other Non-Current Liabilities | 2.4M | 2.97M | 2.63M | 8.81M | 14.19M | 12.71M | 19.27M | 22.96M | 31.01M | 52.93M |
Total Liabilities | 22.89M | 32.94M | 1.53B | 1.33B | 1.25B | 1.19B | 1.13B | 1.33B | 1.32B | 1.26B |
Total Debt | 0 | 0 | 1.3B | 1.07B | 1.01B | 994.49M | 933.14M | 1.11B | 1B | 984.68M |
Net Debt | -199.47M | -361.48M | 1.11B | 746.17M | 782.82M | 740.22M | 529.16M | 812.57M | 682.55M | 719.31M |
Debt / Equity | - | - | 1.26x | 0.78x | 0.54x | 0.52x | 0.46x | 0.52x | 0.48x | 0.48x |
Debt / EBITDA | - | - | 7.91x | 5.49x | 5.67x | 5.00x | 3.32x | 2.82x | 3.11x | 3.13x |
Net Debt / EBITDA | -2.83x | -3.77x | 6.75x | 3.81x | 4.40x | 3.72x | 1.88x | 2.07x | 2.12x | 2.28x |
Interest Coverage | 191.47x | - | 2.74x | 1.12x | -0.94x | 0.21x | 2.33x | 2.89x | 5.64x | 6.01x |
Total Equity | 346.27M▲ 0% | 477.08M▲ 37.8% | 1.03B▲ 116.0% | 1.38B▲ 33.8% | 1.85B▲ 34.4% | 1.9B▲ 2.3% | 2.04B▲ 7.4% | 2.11B▲ 3.9% | 2.11B▼ 0.4% | 2.05B▲ 0% |
Equity Growth % | 32.2% | 37.77% | 115.96% | 33.82% | 34.37% | 2.32% | 7.35% | 3.93% | -0.36% | -4.02% |
Book Value per Share | 5.60 | 7.53 | 15.05 | 18.22 | 22.28 | 22.45 | 23.40 | 23.81 | 24.09 | 24.09 |
Total Shareholders' Equity | 346.27M | 477.08M | 1.03B | 1.38B | 1.85B | 1.9B | 2.04B | 2.11B | 2.11B | 2.05B |
Common Stock | 6K | 6K | 7K | 8K | 8K | 8K | 9K | 9K | 8K | 8K |
Retained Earnings | 85.3M | 171.85M | 211.51M | 220.35M | 176.06M | 149.92M | 205.63M | 209.27M | 195.91M | 177.2M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -269K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.71M | -31.75M |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HQY Cash Flow Statement
HealthEquity, Inc. (HQY) cash flow — operating, investing & free cash flow history
| Metric | Jan'18 | Jan'19 | Jan'20 | Jan'21 | Jan'22 | Jan'23 | Jan'24 | Jan'25 | Jan'26 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 81.7M | 113.42M | 105.86M | 181.62M | 141M | 150.65M | 242.83M | 339.86M | 457.09M | 489.88M |
Operating CF Margin % | 35.6% | 39.49% | 19.9% | 24.76% | 18.64% | 17.48% | 24.29% | 28.33% | 34.8% | - |
Operating CF Growth % | 79.21% | 38.82% | -6.67% | 71.57% | -22.37% | 6.85% | 61.19% | 39.96% | 34.5% | 185% |
Net Income | 47.36M | 73.9M | 39.66M | 8.83M | -44.29M | -26.14M | 55.71M | 96.7M | 215.2M | 230.7M |
Depreciation & Amortization | 15.95M | 18.18M | 55.35M | 115.9M | 137.19M | 161.2M | 153.08M | 162.45M | 154.66M | 154.13M |
Stock-Based Compensation | 14.31M | 21.06M | 39.84M | 42.86M | 52.75M | 62.61M | 77.15M | 96.42M | 73.06M | 78.13M |
Deferred Taxes | 4.31M | 408K | 3.67M | -5.13M | -23.43M | -17.18M | -13.99M | -12.84M | 39.73M | 48.51M |
Other Non-Cash Items | 220K | 1.17M | -23.15M | 6.86M | 17.15M | 3.53M | 4.01M | 3.64M | 1.06M | 878K |
Working Capital Changes | -448K | -1.3M | -9.52M | 12.29M | 1.63M | -33.37M | -33.13M | -6.53M | -26.62M | -22.48M |
Change in Receivables | -4.73M | -4.31M | -6.13M | -413K | -11.2M | -9.57M | -8.06M | -13.11M | -5.69M | -5.75M |
Change in Inventory | 377K | -2.29M | -4.1M | -30.42M | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -581K | 863K | -3.84M | 30.42M | -2.18M | -26.67M | -204K | 8.89M | 1.71M | -2.59M |
Cash from Investing | -36.75M | 25.65M | -1.74B | -96.96M | -639.25M | -119.13M | -46.07M | -505.45M | -47.14M | -44.9M |
Capital Expenditures | -33.38M | -15.04M | -42.07M | -96.96M | -137.08M | -119.13M | -1.69M | -2.08M | -1.97M | -2.25M |
CapEx % of Revenue | 14.54% | 5.24% | 7.91% | 13.22% | 18.12% | 13.82% | 0.17% | 0.17% | 0.15% | 0.17% |
Acquisitions | -2.88M | 11.17M | -1.65B | 0 | -504.53M | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -27.93M | -11.17M | -34.79M | 0 | -128.17M | 0 | -44.38M | -503.37M | -45.17M | -42.66M |
Cash from Financing | 14.56M | 22.93M | 1.47B | 52.42M | 394.86M | -2.67M | -47.04M | 57.57M | -386.98M | -467.51M |
Debt Issued (Net) | 0 | 0 | 1.24B | -239.06M | -65.05M | -8.75M | -54.38M | 171.25M | -100M | -115M |
Equity Issued (Net) | 14.56M | 22.93M | 469.84M | 295.35M | 466.39M | 6.68M | 6.47M | -112.06M | -287.84M | -352.64M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -121.49M | -299.25M | -363.5M |
Other Financing | 0 | 0 | -244.29M | -3.86M | -6.49M | -603K | 865K | -1.62M | 867K | 132K |
Net Change in Cash | 59.52M▲ 0% | 162M▲ 172.2% | -169.75M▼ 204.8% | 137.08M▲ 180.8% | -103.39M▼ 175.4% | 28.85M▲ 127.9% | 149.71M▲ 418.9% | -108.03M▼ 172.2% | 22.98M▲ 121.3% | -22.52M▲ 0% |
Free Cash Flow | 48.32M▲ 0% | 98.38M▲ 103.6% | 63.78M▼ 35.2% | 84.66M▲ 32.7% | 3.91M▼ 95.4% | 31.52M▲ 705.4% | 196.75M▲ 524.2% | 337.77M▲ 71.7% | 455.13M▲ 34.7% | 487.64M▲ 0% |
FCF Margin % | 21.05% | 34.25% | 11.99% | 11.54% | 0.52% | 3.66% | 19.68% | 28.15% | 34.65% | 36.47% |
FCF Growth % | 46.79% | 103.61% | -35.17% | 32.72% | -95.38% | 705.39% | 524.15% | 71.67% | 34.74% | 457.18% |
FCF per Share | 0.78 | 1.55 | 0.93 | 1.12 | 0.05 | 0.37 | 2.26 | 3.80 | 5.20 | 5.74 |
FCF Conversion (FCF/Net Income) | 1.73x | 1.53x | 2.67x | 20.56x | -3.18x | -5.76x | 4.36x | 3.51x | 2.12x | 2.11x |
Interest Paid | 203K | 203K | 21.81M | 0 | 0 | 43.57M | 49.56M | 58.59M | 0 | 0 |
Taxes Paid | 27K | 587K | 9.28M | 0 | 0 | 1.53M | 35.35M | 26.07M | 0 | 0 |
HQY Key Ratios
HealthEquity, Inc. (HQY) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 15.57% | 17.95% | 5.26% | 0.73% | -2.74% | -1.4% | 2.83% | 4.66% | 10.19% | 10.94% |
Return on Invested Capital (ROIC) | 30.37% | 44.4% | 7.26% | 2.81% | 1.28% | 1.07% | 3.7% | 6.28% | 8.46% | 9.05% |
Gross Margin | 56.66% | 61.02% | 54.74% | 46.25% | 45.06% | 45.9% | 53.01% | 57.73% | 69.52% | 72.7% |
Net Margin | 20.63% | 25.73% | 7.46% | 1.2% | -5.85% | -3.03% | 5.57% | 8.06% | 16.38% | 17.25% |
Debt / Equity | - | - | 1.26x | 0.78x | 0.54x | 0.52x | 0.46x | 0.52x | 0.48x | 0.48x |
Interest Coverage | 191.47x | - | 2.74x | 1.12x | -0.94x | 0.21x | 2.33x | 2.89x | 5.64x | 6.01x |
FCF Conversion | 1.73x | 1.53x | 2.67x | 20.56x | -3.18x | -5.76x | 4.36x | 3.51x | 2.12x | 2.11x |
Revenue Growth | 28.68% | 25.15% | 85.21% | 37.89% | 3.13% | 13.9% | 16% | 20.03% | 9.47% | 7.58% |
Related:HQY Dividend History·HQY Revenue History·HQY Price History·HQY P/E History·HQY Financial Ratios·HQY Institutional Holders
HQY SEC Filings & Documents
HealthEquity, Inc. (HQY) SEC filings — annual & quarterly reports (10-K, 10-Q)
HQY Frequently Asked Questions
HealthEquity, Inc. (HQY) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
HealthEquity, Inc. (HQY) reported $1.34B in revenue for fiscal year 2026. This represents a 2801% increase from $46.1M in 2013.
HealthEquity, Inc. (HQY) grew revenue by 9.5% over the past year. This is steady growth.
Yes, HealthEquity, Inc. (HQY) is profitable, generating $230.7M in net income for fiscal year 2026 (16.4% net margin).
Dividend & Returns
HealthEquity, Inc. (HQY) has a return on equity (ROE) of 10.2%. This is reasonable for most industries.
HealthEquity, Inc. (HQY) generated $487.6M in free cash flow for fiscal year 2026. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.